KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Cash from Financing Activities (2016 - 2026)

Bristol Myers Squibb has reported Cash from Financing Activities over the past 18 years, most recently at -$1.6 billion for Q1 2026.

  • Quarterly Cash from Financing Activities fell 57.1% to -$1.6 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$10.9 billion through Mar 2026, down 3.85% year-over-year, with the annual reading at -$10.3 billion for FY2025, 301.83% down from the prior year.
  • Cash from Financing Activities was -$1.6 billion for Q1 2026 at Bristol Myers Squibb, up from -$6.0 billion in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $14.6 billion in Q1 2024 and troughed at -$6.0 billion in Q4 2025.
  • The 5-year median for Cash from Financing Activities is -$3.1 billion (2023), against an average of -$2.0 billion.
  • The largest YoY upside for Cash from Financing Activities was 580.13% in 2024 against a maximum downside of 269.8% in 2024.
  • A 5-year view of Cash from Financing Activities shows it stood at -$3.2 billion in 2022, then skyrocketed by 129.79% to $967.0 million in 2023, then tumbled by 269.8% to -$1.6 billion in 2024, then crashed by 267.17% to -$6.0 billion in 2025, then skyrocketed by 74.13% to -$1.6 billion in 2026.
  • Per Business Quant, the three most recent readings for BMY's Cash from Financing Activities are -$1.6 billion (Q1 2026), -$6.0 billion (Q4 2025), and -$1.5 billion (Q3 2025).